Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;49 Suppl 1(Suppl 1):S44-S52.
doi: 10.1002/hast.1016.

Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics

Jada G Hamilton, Mark E Robson

Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics

Jada G Hamilton et al. Hastings Cent Rep. 2019 May.

Abstract

In recent years, with both the development of next-generation sequencing approaches and the Supreme Court decision invalidating gene patents, declining costs have contributed to the emergence of a new model of hereditary cancer genetic testing. Multigene panel testing (or multiplex testing) involves using next-generation sequencing technology to determine the sequence of multiple cancer-susceptibility genes. In addition to high-penetrance cancer-susceptibility genes, multigene panels frequently include genes that are less robustly associated with cancer predisposition. Scientific understanding about associations between many specific moderate-penetrance gene variants and cancer risks is incomplete. The emergence of multigene panel tests has created unique challenges that may have meaningful psychosocial implications. Contrasted with the serial testing process, wherein patients consider the personal and clinical implications of each evaluated gene, with multigene panel testing, patients provide broad consent to whichever genes are included in a particular panel and then, after the test, receive in-depth genetic counseling to clarify the distinct implications of their specific results. Consequently, patients undergoing multigene panel testing may have a less nuanced understanding of the test and its implications, and they may have fewer opportunities to self-select against the receipt of particular types of genetic-risk information. Evidence is conflicting regarding the emotional effects of this testing.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no conflicts of interest.

References

    1. Antoniou A. et al., “Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies,” American Journal of Human Genetics 72, no. 5 (2003): 1117–30. - PMC - PubMed
    1. Breast Cancer Linkage Consortium, “Cancer Risks in BRCA2 Mutation Carriers,” Journal of the National Cancer Institute 91, no. 15 (1999): 1310–16; - PubMed
    2. Thompson D and Easton DF, “Cancer Incidence in BRCA1 Mutation Carriers,” Journal of the National Cancer Institute 94, no. 18 (2002): 1358–65. - PubMed
    1. Weitzel JN et al., “Genetics, Genomics, and Cancer Risk Assessment: State of the Art and Future Directions in the Era of Personalized Medicine,” CA: A Cancer Journal for Clinicians 61 (2011): 327–59. - PMC - PubMed
    1. Wade CH, “What Is the Psychosocial Impact of Providing Genetic and Genomic Health Information to Individuals? An Overview of Systematic Reviews,” Looking for the Psychosocial Impacts of Genomic Information, special report, Hastings Center Report 49, no. 3 (2019): S88–S96. - PubMed
    1. Butow PN et al. “Psychological Outcomes and Risk Perception after Genetic Testing and Counselling in Breast Cancer: A Systematic Review,” Medical Journal of Australia 178, no. 2 (2003): 77–81; - PubMed
    2. Meiser B, “Psychological Impact of Genetic Testing for Cancer Susceptibility: An Update of the Literature,” Psycho-Oncology 14, no. 12 (2005): 1060–74; - PubMed
    3. Schlich-Bakker KJ et al., “A Literature Review of the Psychological Impact of Genetic Testing on Breast Cancer Patients,” Patient Education and Counseling 62, no. 1 (2006): 13–20; - PubMed
    4. Heshka JT et al., “A Systematic Review of Perceived Risks, Psychological and Behavioral Impacts of Genetic Testing,” Genetics in Medicine 10, no. 1 (2008): 19–32; - PubMed
    5. Hamilton JG et al., “Emotional Distress following Genetic Testing for Hereditary Breast and Ovarian Cancer: A Meta-analytic Review,” Health Psychology 28, no. 4 (2009): 510–18. - PMC - PubMed